When Is a Autologous Bone Marrow Transplantation Indicated in the Treatment of Juvenile Systemic Sclerorsis? Results of a Multinational Survey of Pediatric Rheumatologist

Pediatric Rheumatology - United Kingdom
doi 10.1186/1546-0096-9-s1-p73
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search